(1) Cloning sequencing and expression of SPE7 Fv. SPE7 Fv was cloned from cDNA of the SPE7.49 hybridoma (1) into a pUC vector to append pelB leaders on both chains and a 6xHis tag on the heavy chain (2) . Its sequence was found to be most similar to IgG anti-NP antibody B1-8 (3) -a germline antibody with heavy chain V gene VH186.2 and light chain gene VL lambda 1 (Fig. S1 below) .
The Fv fragment was expressed in the periplasm of E. coli and purified by Ni-NTA chromatography essentially as described (2) . Samples for crystallization were further purified by gel filtration (S-200) where only a monomeric species was observed, and dialyzed into 10 mM HEPES pH 7. Affinity measurements at equilibrium were performed with the intact SPE7 antibody (Sigma) or its recombinant Fv fragment, by either fluorescence quenching titration (for Kd <1 µM) or competitive ELISA for the lower affinity ligands (4) . 
(2) Pre-steady-state kinetics
Pre-steady-state kinetics were performed and analyzed as described (4) using SPE7 Fv at 1 µM concentration in PBS (50 mM sodium phosphate, 100 mM sodium chloride, pH 7)
at 20°C. Data from at least 3 independent reactions were averaged for each ligand concentration. Individual phases were generally traced for KDOIOLYHV 'DWD FROOHFWHG within the dead time of the instrument (2 ms) was discarded before fitting with the program Kaleidagraph. Fits to a single exponential were performed with equation (I): F t = F 0 . exp(-(1/τ) . t) + F ∞ ; where F t is the fluorescence (in arbitrary units) at time t ; F 0 is the fluorescence of the free (uncomplexed) antibody; 1/τ (or k observed ) is the reciprocal relaxation time; F ∞ is the fluorescence at equilibrium (at t=∞).
(3) Crystal structure determination
Crystals were grown by the hanging drop method under the conditions described in Table   1 . Hapten co-crystallization (Ab3) was performed by co-concentrating antibody with hapten (due to low hapten solubility). The Trx-Shear3:Ab complex (Ab4) was cocrystallized by adding equimolar amounts of the independently purified and expressed proteins. For data collection, crystals were frozen at 100K in a cryo-stream without addition of cryo-protectant. All datasets were collected on a rotating anode with a Mar-345 image plate detector. A single crystal was used in each dataset. Data were indexed using MOSFLM and scaled in SCALA (5). All structures were determined by AMORE molecular replacement using the antibody B1-8 (1A6V) (5) . Structures Ab1 and Ab3
were refined using REFMAC and ARP/warp (5) with rebuilding in O (6). Ab4 was refined in BUSTER (7) and Ab2 in SHELXL97 (8) and CNS (9).
Ab1 isomer. The structure of free isomer Ab1 crystallizes in spacegroup P212121 with one of each chain, H and L, per asymmetric unit (a.u.). The main packing interactions, involving CDR loops, occur between the CDR 2 of H and L and are reproduced in all the other structures. There is a single crystal packing interaction involving H3 (which is also reproduced in the Ab3 structures) and none involving L3.
Ab2 isomer. The structure of free isomer Ab2 crystallizes in an apparent spacegroup of I422 but the cell is not large enough to accommodate 2 copies per a.u. Twinning was detected following examination of the acentric cumulative intensity distribution, which was sigmoidal ( Figure S2 ). Twinning was not unambiguously indicated from the Model and data quality. All structures were validated using the program PROCHECK (5) . In all structures, residues for SPE7 are located in either energetically favored or allowed regions on a Ramachandran plot with the exception of Thr53L (see Figure S4 , an example plot for Ab1). This residue forms part of a classic gamma-turn, which explains the unfavorable Phi-Psi value. In the Fv-thioredoxin structure there are no thioredoxin residues in disallowed regions. Data quality for all structures was good, as expected at high resolution, with the exception of the disordered regions in chains I and K in Ab3 models. Views of the electron density for conformations Ab1-Ab4, describing regions around the L3 and H3 loops, is presented in Figure S5 Part's A and B.
Temperature factors. A comprehensive break-down of the temperature factors for all structures is given in Table S1 Sample homogeneity. All structures were crystallized from protein prepared from a single clone of the recombinant Fv fragment of SPE7 expressed in E. coli. Thus, the differences in conformation cannot be ascribed to heterogeneity of sequence.
Nevertheless, Figure 6S shows OMIT maps of the pivotal Trp93L from the two native structures Ab1 and Ab2 demonstrating that the side chain is correct and the density is unequivocal. Figure S2 . Plot of the cumulative intensity distribution for the twinned structure of the free antibody isomer Ab2. 
Selection of the Trx-protein ligands
The Trx-protein ligands ( Figure 4 of the article) were isolated using the FliTrx system (Invitrogen) that displays on the surface of E. coli a cyclic peptide library in place of the active site loop of thioredoxin (10) . SPE7 was immobilized on plates and incubated with the library. Unbound bacteria were washed away and bound bacteria removed either by applying shear stress or by adding 0.5 mM DNP. Initial estimates of affinity were determined by ELISA using an HRP labeled anti-thioredoxin antibody. Selected clones were then sequenced and the Trx proteins re-cloned into the Invitrogen pCR-T7-TOPO vector, expressed and purified by Ni-NTA and size exclusion chromatography. Affinities were then measured by ELISA using purified protein. SPE7/Trx complexed crystals were prepared by adding equimolar amounts of the separately prepared proteins.
